Literature DB >> 17640912

Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells.

Jian Xu1, Scott D Pope, Ali R Jazirehi, Joanne L Attema, Peter Papathanasiou, Jason A Watts, Kenneth S Zaret, Irving L Weissman, Stephen T Smale.   

Abstract

Recent studies have suggested that, in ES cells, inactive genes encoding early developmental regulators possess bivalent histone modification domains and are therefore poised for activation. However, bivalent domains were not observed at typical tissue-specific genes. Here, we show that windows of unmethylated CpG dinucleotides and putative pioneer factor interactions mark enhancers for at least some tissue-specific genes in ES cells. The unmethylated windows expand in cells that express the gene and contract, disappear, or remain unchanged in nonexpressing tissues. However, in ES cells, they do not always coincide with common histone modifications. Genomic footprinting and chromatin immunoprecipitation demonstrated that transcription factor binding underlies the unmethylated windows at enhancers for the Ptcra and Alb1 genes. After stable integration of premethylated Ptcra enhancer constructs into the ES cell genome, the unmethylated windows readily appeared. In contrast, the premethylated constructs remained fully methylated and silent after introduction into Ptcra-expressing thymocytes. These findings provide initial functional support for a model in which pioneer factor interactions in ES cells promote the assembly of a chromatin structure that is permissive for subsequent activation, and in which differentiated tissues lack the machinery required for gene activation when these ES cell marks are absent. The enhancer marks may therefore represent important features of the pluripotent state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640912      PMCID: PMC1941477          DOI: 10.1073/pnas.0704579104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

2.  Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.

Authors:  Lisa Ann Cirillo; Frank Robert Lin; Isabel Cuesta; Dara Friedman; Michal Jarnik; Kenneth S Zaret
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

3.  Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway.

Authors:  Boris Reizis; Philip Leder
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

4.  Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin.

Authors:  D Chaya; T Hayamizu; M Bustin; K S Zaret
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 5.  Epigenetic reprogramming in mammalian development.

Authors:  W Reik; W Dean; J Walter
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

6.  The role of DNA methylation in mammalian epigenetics.

Authors:  P A Jones; D Takai
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

7.  Identification of clonogenic common lymphoid progenitors in mouse bone marrow.

Authors:  M Kondo; I L Weissman; K Akashi
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

8.  Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions.

Authors:  W C Forrester; L A Fernández; R Grosschedl
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

9.  Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.

Authors:  J L Christensen; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

10.  The upstream enhancer is necessary and sufficient for the expression of the pre-T cell receptor alpha gene in immature T lymphocytes.

Authors:  B Reizis; P Leder
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  64 in total

1.  Sequentially acting Sox transcription factors in neural lineage development.

Authors:  Maria Bergsland; Daniel Ramsköld; Cécile Zaouter; Susanne Klum; Rickard Sandberg; Jonas Muhr
Journal:  Genes Dev       Date:  2011-11-15       Impact factor: 11.361

2.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood.

Authors:  Gidon Toperoff; Dvir Aran; Jeremy D Kark; Michael Rosenberg; Tatyana Dubnikov; Batel Nissan; Julio Wainstein; Yechiel Friedlander; Ephrat Levy-Lahad; Benjamin Glaser; Asaf Hellman
Journal:  Hum Mol Genet       Date:  2011-10-12       Impact factor: 6.150

3.  Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis.

Authors:  Joanne L Attema; Peter Papathanasiou; E Camilla Forsberg; Jian Xu; Stephen T Smale; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

4.  Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.

Authors:  Jérôme Eeckhoute; Mathieu Lupien; Clifford A Meyer; Michael P Verzi; Ramesh A Shivdasani; X Shirley Liu; Myles Brown
Journal:  Genome Res       Date:  2009-01-07       Impact factor: 9.043

Review 5.  Chromatin "pre-pattern" and epigenetic modulation in the cell fate choice of liver over pancreas in the endoderm.

Authors:  Cheng-Ran Xu; Kenneth S Zaret
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

Review 6.  Recommendations for the design and analysis of epigenome-wide association studies.

Authors:  Karin B Michels; Alexandra M Binder; Sarah Dedeurwaerder; Charles B Epstein; John M Greally; Ivo Gut; E Andres Houseman; Benedetta Izzi; Karl T Kelsey; Alexander Meissner; Aleksandar Milosavljevic; Kimberly D Siegmund; Christoph Bock; Rafael A Irizarry
Journal:  Nat Methods       Date:  2013-10       Impact factor: 28.547

7.  Transcriptional competence in pluripotency.

Authors:  Edupuganti V S Raghu Ram; Eran Meshorer
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

8.  Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells.

Authors:  Jian Xu; Jason A Watts; Scott D Pope; Paul Gadue; Mark Kamps; Kathrin Plath; Kenneth S Zaret; Stephen T Smale
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

Review 9.  The transcriptional foundation of pluripotency.

Authors:  Ian Chambers; Simon R Tomlinson
Journal:  Development       Date:  2009-07       Impact factor: 6.868

Review 10.  Human genetic variation within neural crest enhancers: molecular and phenotypic implications.

Authors:  Alvaro Rada-Iglesias; Sara L Prescott; Joanna Wysocka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.